Newsfeeds - Spark Newswire

1 minute read

Analyst Sees Deteriorated Treatment Effect Of Blueprint’s Much Awaited Mastocytosis Data

Today, 3:36 AM

Earlier today, Blueprint Medicines Corporation (NASDAQ: BPMC) released the long-awaited pivotal PIONEER dataset in Indolent Systemic Mastocytosis (ISM). The topline data indicates that…

BPMC

2 minute read

Sanofi, Children’s Place And Some Other Big Stocks Moving Lower On Wednesday

By Lisa Levin

Today, 3:36 AM

Embark Technology, Inc. (NASDAQ: EMBK) fell 25.1% to $12.40. Embark Technology reported the completion of reverse stock split.

ARVN

4 minute read

Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

Today, 3:36 AM

Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 79.5% to $4.57 after the company announced it plans to explore the potential development of a novel monkeypox vaccine using its norovirus shell and protrusion virus-like particle platform.

1 minute read

HC Wainwright & Co. Maintains Buy on Blueprint Medicines, Lowers Price Target to $80

By Benzinga Newsdesk

Today, 3:36 AM

HC Wainwright & Co. analyst Andrew Fein maintains Blueprint Medicines (NASDAQ:BPMC) with a Buy and lowers the price target from $100 to $80.

BPMC

3 minute read

U.S. Stocks Open Lower; Nasdaq Down 150 Points

By Lisa Levin

Today, 3:36 AM

U.S. stocks traded lower this morning, with the Nasdaq composite dropping more than 150 points on Wednesday.

ARTL

1 minute read

Blueprint Medicines Stock Is Getting Hammered Wednesday: What’s Happening?

By Henry Khederian

Today, 3:36 AM

Blueprint Medicines Corp (NASDAQ: BPMC) shares are trading lower by 22.2% to $53.32 Wednesday morning after the company announced top-line results from the registrational Part 2 of the PIONEER clinical trial of AYVAKIT in patients with non-advanced systemic mastocytosis.

BPMC